About Rivastigmine Hydrogen Tartrate
Class: | Cholinesterase inhibitor
Use: | Treatment of mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease
Adult dose: | Initial dose: 1.5 mg twice daily; may be increased to 3 mg twice daily after 4 weeks based on tolerability; maximum dose: 6 mg twice daily
Pediatric dose: | Not established; not recommended for pediatric use
Side effects: | Nausea, vomiting, diarrhea, loss of appetite, weight loss, abdominal pain, fatigue, dizziness, headache
Contrain
Drug Class
Cholinesterase inhibitor
Uses & Indications
Treatment of mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease
Storage Requirements
Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture
Manufacturer & Packaging
Manufacturer: Novartis Pharma AG, SWITZERLAND
Package Size
60's Bottle
Price & Supplier
Price in UAE: AED 424.50
Dosage Information
Adult Dose
Initial dose: 1.5 mg twice daily; may be increased to 3 mg twice daily after 4 weeks based on tolerability; maximum dose: 6 mg twice daily
Pediatric Dose
Not established; not recommended for pediatric use
Side Effects
Nausea, vomiting, diarrhea, loss of appetite, weight loss, abdominal pain, fatigue, dizziness, headache
Contraindications & Precautions
Known hypersensitivity to rivastigmine or any component of the formulation; history of severe skin reactions to transdermal rivastigmine
Important Warnings
May cause bradycardia, gastrointestinal bleeding, and seizures; caution in patients with a history of asthma or obstructive pulmonary disease; monitor for signs of cholinergic crisis
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.